807 related articles for article (PubMed ID: 28100738)
1. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
2. MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis.
De Vito F; Musella A; Fresegna D; Rizzo FR; Gentile A; Stampanoni Bassi M; Gilio L; Buttari F; Procaccini C; Colamatteo A; Bullitta S; Guadalupi L; Caioli S; Vanni V; Balletta S; Sanna K; Bruno A; Dolcetti E; Furlan R; Finardi A; Licursi V; Drulovic J; Pekmezovic T; Fusco C; Bruzzaniti S; Hornstein E; Uccelli A; Salvetti M; Matarese G; Centonze D; Mandolesi G
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12765. PubMed ID: 34490928
[TBL] [Abstract][Full Text] [Related]
3. MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling.
Liu X; Zhou F; Yang Y; Wang W; Niu L; Zuo D; Li X; Hua H; Zhang B; Kou Y; Guo J; Kong F; Pan W; Gao D; Meves JM; Sun H; Xue M; Zhang Q; Wang Y; Tang R
Glia; 2019 Jan; 67(1):101-112. PubMed ID: 30294880
[TBL] [Abstract][Full Text] [Related]
4. IL-1β dependent cerebellar synaptopathy in a mouse mode of multiple sclerosis.
Mandolesi G; Gentile A; Musella A; Centonze D
Cerebellum; 2015 Feb; 14(1):19-22. PubMed ID: 25326653
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.
Mandolesi G; Musella A; Gentile A; Grasselli G; Haji N; Sepman H; Fresegna D; Bullitta S; De Vito F; Musumeci G; Di Sanza C; Strata P; Centonze D
J Neurosci; 2013 Jul; 33(29):12105-21. PubMed ID: 23864696
[TBL] [Abstract][Full Text] [Related]
6. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.
Gentile A; Musella A; De Vito F; Fresegna D; Bullitta S; Rizzo FR; Centonze D; Mandolesi G
J Neuroinflammation; 2018 Jan; 15(1):5. PubMed ID: 29304807
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1β promotes long-term potentiation in patients with multiple sclerosis.
Mori F; Nisticò R; Mandolesi G; Piccinin S; Mango D; Kusayanagi H; Berretta N; Bergami A; Gentile A; Musella A; Nicoletti CG; Nicoletti F; Buttari F; Mercuri NB; Martino G; Furlan R; Centonze D
Neuromolecular Med; 2014 Mar; 16(1):38-51. PubMed ID: 23892937
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis.
Morquette B; Juźwik CA; Drake SS; Charabati M; Zhang Y; Lécuyer MA; Galloway DA; Dumas A; de Faria Junior O; Paradis-Isler N; Bueno M; Rambaldi I; Zandee S; Moore C; Bar-Or A; Vallières L; Prat A; Fournier AE
Brain; 2019 Oct; 142(10):2979-2995. PubMed ID: 31412103
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis.
Talebi F; Ghorbani S; Chan WF; Boghozian R; Masoumi F; Ghasemi S; Vojgani M; Power C; Noorbakhsh F
J Neuroinflammation; 2017 Mar; 14(1):55. PubMed ID: 28302134
[TBL] [Abstract][Full Text] [Related]
10. MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis.
De Vito F; Balletta S; Caioli S; Musella A; Guadalupi L; Vanni V; Fresegna D; Bassi MS; Gilio L; Sanna K; Gentile A; Bruno A; Dolcetti E; Buttari F; Pavone L; Furlan R; Finardi A; Perlas E; Hornstein E; Centonze D; Mandolesi G
Curr Neuropharmacol; 2023; 21(12):2567-2582. PubMed ID: 37021418
[TBL] [Abstract][Full Text] [Related]
11. Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis.
Musumeci G; Grasselli G; Rossi S; De Chiara V; Musella A; Motta C; Studer V; Bernardi G; Haji N; Sepman H; Fresegna D; Maccarrone M; Mandolesi G; Centonze D
Neurobiol Dis; 2011 Sep; 43(3):669-77. PubMed ID: 21672630
[TBL] [Abstract][Full Text] [Related]
12. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
Musella A; Gentile A; Guadalupi L; Rizzo FR; De Vito F; Fresegna D; Bruno A; Dolcetti E; Vanni V; Vitiello L; Bullitta S; Sanna K; Caioli S; Balletta S; Nencini M; Buttari F; Stampanoni Bassi M; Centonze D; Mandolesi G
Cells; 2020 May; 9(5):. PubMed ID: 32455907
[TBL] [Abstract][Full Text] [Related]
13. Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis.
Mitosek-Szewczyk K; Sulkowski G; Stelmasiak Z; Struzyńska L
Neuroscience; 2008 Jul; 155(1):45-52. PubMed ID: 18572325
[TBL] [Abstract][Full Text] [Related]
14. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
[TBL] [Abstract][Full Text] [Related]
15. In vivo silencing of miR-125a-3p promotes myelin repair in models of white matter demyelination.
Marangon D; Boda E; Parolisi R; Negri C; Giorgi C; Montarolo F; Perga S; Bertolotto A; Buffo A; Abbracchio MP; Lecca D
Glia; 2020 Oct; 68(10):2001-2014. PubMed ID: 32163190
[TBL] [Abstract][Full Text] [Related]
16. miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40.
Mycko MP; Cichalewska M; Cwiklinska H; Selmaj KW
J Neurosci; 2015 Dec; 35(50):16504-15. PubMed ID: 26674874
[TBL] [Abstract][Full Text] [Related]
17. Absence of system x
Merckx E; Albertini G; Paterka M; Jensen C; Albrecht P; Dietrich M; Van Liefferinge J; Bentea E; Verbruggen L; Demuyser T; Deneyer L; Lewerenz J; van Loo G; De Keyser J; Sato H; Maher P; Methner A; Massie A
J Neuroinflammation; 2017 Jan; 14(1):9. PubMed ID: 28086920
[TBL] [Abstract][Full Text] [Related]
18. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
[TBL] [Abstract][Full Text] [Related]
19. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Berard JL; Zarruk JG; Arbour N; Prat A; Yong VW; Jacques FH; Akira S; David S
Glia; 2012 Jul; 60(7):1145-59. PubMed ID: 22499213
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
Gentile A; Fresegna D; Federici M; Musella A; Rizzo FR; Sepman H; Bullitta S; De Vito F; Haji N; Rossi S; Mercuri NB; Usiello A; Mandolesi G; Centonze D
Neurobiol Dis; 2015 Feb; 74():347-58. PubMed ID: 25511803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
